# Secondary Findings From High-throughput Sequencing: How to Announce Them With Respect to the Patient's Needs

> **NCT03288727** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 342 (actual)

## Conditions studied

- Development Disorders

## Interventions

- **OTHER:** interviews with a psychologist

## Key facts

- **NCT ID:** NCT03288727
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-13
- **Primary completion:** 2021-11-24
- **Final completion:** 2021-11-24
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03288727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03288727, "Secondary Findings From High-throughput Sequencing: How to Announce Them With Respect to the Patient's Needs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03288727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*